SINK SIDE
NOTESSKIN-CARE DECISIONPRACTICAL CALL

U.S. ROUTINE CONTEXT · PRACTICAL CALL

Approach retinoid-style anti-aging products with irritation and pregnancy in mind

Understand the formula, introduction plan, and situations that require individualized professional guidance.

NOTE 01

OUR SINK-SIDE CALL

The route we would take.

Pregnant or trying? Do not start the retinoid; pause and verify it

NOTE 02

Where the call changes.

CHOOSE DIFFERENTLY WHEN

  • Do not change an established prescription plan without contacting the prescribing clinician.
  • Pregnancy and breastfeeding questions should not be settled by a generic ranking.

WHAT WE ARE NOT CLAIMING

  • Exact concentrations, material origin and quality, reformulation history, and online ingredient-list synchronization are often missing.

NOTE 03

HOW TO READ THIS NOTE

Evidence without theater.

This page makes an editorial call from documented context. It does not claim a product was owned, used, ranked, or independently tested. Manufacturer statements never become our results.

EVIDENCE TRAIL

What the sources carry — and what the desk decides.

The linked sources support product status, labeling, or professional boundaries. They do not prove the editorial winner and they do not stand in for an owned test.

EDITORIAL JUDGMENT

Pregnant or trying? Do not start the retinoid; pause and verify it

A reasoned course of action; not a product result measured by the source.
BOUNDARY OF THE CALL

Do not change an established prescription plan without contacting the prescribing clinician.

Sink Side Notes cannot assess an individual pregnancy, exposure, prescription, or product safety remotely.

Primary and professional sources in the record

  1. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)U.S. Food and Drug Administration
  2. Cosmetics Labeling ClaimsU.S. Food and Drug Administration
  3. Summary of Cosmetics Labeling RequirementsU.S. Food and Drug Administration
  4. 21 CFR Part 701 — Cosmetic LabelingOffice of the Federal Register / eCFR
  5. Final Administrative Order OTC000039 — M020 Sunscreen Drug ProductsU.S. Food and Drug Administration
  6. 21 CFR 201.327 — OTC sunscreen labeling and effectiveness testingOffice of the Federal Register / eCFR
  7. Sunscreen: How to Help Protect Your Skin from the SunU.S. Food and Drug Administration
  8. 21 CFR Part 740 — Cosmetic Product Warning StatementsOffice of the Federal Register / eCFR
  9. FDA Adverse Event Monitoring System (AEMS)U.S. Food and Drug Administration
  10. Dermatologist-approved pregnancy skin careAmerican Academy of Dermatology Association